Nonylphenol in pregnant women and their matching fetuses: Placental transfer and potential risks of infants

被引:55
|
作者
Huang, Yu-Fang [1 ,2 ]
Wang, Pei-Wei [3 ]
Huang, Li-Wei [4 ]
Yang, Winnie [3 ]
Yu, Ching-Jung [1 ]
Yang, Shang-Han [1 ]
Chiu, Hsin-Hao [1 ]
Chen, Mei-Lien [1 ]
机构
[1] Natl Yang Ming Univ, Inst Environm & Occupat Hlth Sci, Taipei 112, Taiwan
[2] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan
[3] Taipei City Hosp, Dept Pediat, Taipei, Taiwan
[4] Taipei City Hosp, Women & Childrens Campus, Dept OBS 8x GYN, Taipei, Taiwan
关键词
Nonylphenol; Mother; Foetus; Placenta; Breast milk; Risk; PERFORMANCE LIQUID-CHROMATOGRAPHY; TANDEM MASS-SPECTROMETRY; SOLID-PHASE EXTRACTION; BISPHENOL-A; DEGRADATION-PRODUCTS; ALKYLPHENOL ETHOXYLATES; GESTATIONAL EXPOSURE; DRINKING-WATER; RIVER WATER; HUMAN-MILK;
D O I
10.1016/j.envres.2014.07.004
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
As the predominant environmental biodegradation product of nonylphenol (NP) ethoxylates and with proven estrogenic effects, NP is formed during the alkylation process of phenols. The purposes of this study were (1) to examine maternal and prenatal exposure to NP in Taiwan, (2) to determine the level of placental protection against NP exposure as well as the level of NP in breast milk, and (3) to assess the potential risk for breastfed newborns exposed to NP through the milk. Thirty pairs of maternal and fetal blood samples, placenta, and breast milk during the 1st and the 3rd months of lactation were collected. External NP exposures of these specimens were then analyzed by using high-performance liquid chromatography coupling with fluorescence detection. Next, the sociodemographics, lifestyle, delivery method, dietary and work history were collected using a questionnaire. In addition, the daily intake of NP from consuming breast milk in the 1st and 3rd months for newborns was studied through deterministic and probabilistic risk assessment methods. The geometric means and geometric standard deviation of NP levels in maternal blood, fetal cord blood, placenta, and breast milk in the 1st and 3rd months were 14.6 (1.7) ng/ml, 18.8 (1.8) ng/ml, 19.8 (1.9) ng/g, 23.5 (3.2) ng/ml, and 573 (1.4) ng/ml, respectively. The probabilistic percentiles (50th, 75th, and 95th) of daily intake NP in breast milk were 4.33, 7.79, and 18.39 mu g/kg-bw/day in the 1st month, respectively, and were 8.11, 10.78, 16.08 mu g/kg-bw/day in the 3rd month, respectively. The probabilistic distributions (5th, 25th, and 50th) of risk for infants aged 1 month old were 0.27, 0.64, and 1.15, respectively, and that for infants aged 3 month old were 0.31, 0.46, and 0.62, respectively. Through repeated exposure from the dietary intake of expectant mothers, fetuses could encounter a high NP exposure level due to transplacental absorption, partitioning between the maternal and fetal compartments. Daily NP intake via breast milk in three month-old babies exceeded the tolerable daily intake (TDI) of 5 mu g/kg bw/day indicated a potential risk for Taiwan infants. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:143 / 148
页数:6
相关论文
共 50 条
  • [21] SERUM LEVELS, PLACENTAL EXPRESSION AND LOCALIZATION OF ANGIOTENSIN CONVERTING ENZYME IN PREGNANT WOMEN WITH UNCOMPLICATED PREGNANCY AND IN WOMEN WITH PREECLAMPSIA AND IUGR FETUSES
    Cosmi, Erich
    Saccardi, Carlo
    Zanardo, Vincenzo
    Chiarelli, Silvia
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2008, 199 (06) : S81 - S81
  • [22] Evaluating Placental Transfer and Tissue Concentrations of Manganese in the Pregnant Rat and Fetuses after Inhalation Exposures with a PBPK Model
    Yoon, Miyoung
    Nong, Andy
    Clewell, Harvey J., III
    Taylor, Michael D.
    Dorman, David C.
    Andersen, Melvin E.
    TOXICOLOGICAL SCIENCES, 2009, 112 (01) : 44 - 58
  • [23] Sertraline concentrations in pregnant women are steady and the drug transfer to their infants is low
    E. Heinonen
    M. Blennow
    M. Blomdahl-Wetterholm
    M. Hovstadius
    J. Nasiell
    A. Pohanka
    L. L. Gustafsson
    K. Wide
    European Journal of Clinical Pharmacology, 2021, 77 : 1323 - 1331
  • [24] ANTIBODY RESPONSE OF PREGNANT WOMEN TO POLIOMYELITIS VACCINE AND PASSIVE TRANSFER TO INFANTS
    BROWN, GC
    CARROLL, CJ
    JOURNAL OF IMMUNOLOGY, 1958, 81 (05): : 389 - 395
  • [25] Sertraline concentrations in pregnant women are steady and the drug transfer to their infants is low
    Heinonen, E.
    Blennow, M.
    Blomdahl-Wetterholm, M.
    Hovstadius, M.
    Nasiell, J.
    Pohanka, A.
    Gustafsson, L. L.
    Wide, K.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (09) : 1323 - 1331
  • [26] Induction of 8-hydroxydeoxyguanosine and ultrastructure alterations by silver nanoparticles attributing to placental transfer in pregnant rats and fetuses
    Salim, E. I.
    Abdel-Halim, K. Y.
    Abu-Risha, S. E.
    Abdel-Latif, A. S.
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2019, 38 (06) : 734 - 745
  • [27] RESPONSE OF PREGNANT WOMEN AND THEIR INFANTS TO POLIOMYELITIS VACCINE - DISTRIBUTION OF POLIOVIRUS ANTIBODY IN PREGNANT WOMEN BEFORE AND AFTER VACCINATION - TRANSFER, PERSISTENCE, AND INDUCTION OF ANTIBODIES IN INFANTS
    DASILVA, MM
    PREM, KA
    JOHNSON, EA
    MCKELVEY, JL
    SYVERTON, JT
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1958, 168 (01): : 1 - 5
  • [28] Low Placental Transfer Rates of Risankizumab Among Pregnant Women With Inflammatory Bowel Disease
    Mahadevan, Uma
    Long, Millie
    INFLAMMATORY BOWEL DISEASES, 2024, 30 (11) : 2240 - 2241
  • [29] Seroprevalence and placental transfer of SARS-CoV-2 antibodies in unvaccinated pregnant women
    Vercoutere, An
    Zina, Mbiton Joel
    Telis, Meltem
    Goffard, Jean-Christophe
    Boulvain, Michel
    de Doncker, Loic
    Derisbourg, Sara
    Houben, Sylvie
    Delforge, Marie-Luce
    Daelemans, Caroline
    Kelen, Dorottya
    BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [30] Risks and Preventions for Pregnant Women and Their Preterm Infants in a World with COVID-19: A Narrative Review
    Ahmed, Abdulrahman K. K.
    Sijercic, Victor Coll
    Sayad, Reem
    Ruthig, Gregory R. R.
    Abdelwahab, Sayed F. F.
    El-Mokhtar, Mohamed A. A.
    Sayed, Ibrahim M. M.
    VACCINES, 2023, 11 (03)